BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 8056047)

  • 1. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C regulates secretion of lymphotoxin (LT/TNF beta) and TNF alpha by human EBV-transformed B cells.
    Jochems GJ; Klein MR; Zeijlemaker WP; van Lier RA
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):162-7. PubMed ID: 1335785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O; Gillis S; Kabelitz D
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor secreted by transformed human B lymphocytes: lack of an autocrine growth effect.
    Pirisi M; Vasiliadis D; Harrison LC
    Lymphokine Res; 1990; 9(1):27-33. PubMed ID: 2157923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Szekely L; Pokrovskaja K; Klein G
    Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
    Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
    J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
    Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
    Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
    Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
    Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
    Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
    Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
    J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
    Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
    Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
    J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
    Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
    Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.